The dismissal of a securities fraud case is a significant legal victory for Organogenesis Holdings Inc., likely leading to increased investor confidence and a positive impact on the stock price. Legal uncertainties can weigh heavily on a company's stock performance, and the resolution of such issues often results in a positive market reaction. Given the nature of the case and its potential implications, this news is highly relevant and important for investors in ORGO.